Scientific Review Panel

The Scientific Review Panel is responsible for reviewing the recommendations of the Scientific Advisory Board and making recommendations for funding of grants to the Board of Directors. The following are members of the Scientific Review Panel:

Joseph Coyle, M.D.
Joseph Coyle, M.D. served as Chairman of the Consolidated Department of Psychiatry at Harvard Medical School from 1991 to 2001. He now holds the Eben S. Draper Chair of Psychiatry and Neuroscience at Harvard. He received his MD degree from Johns Hopkins School of Medicine in 1969. Following an internship in pediatrics, he spent three years at the National Institutes of Health as a research fellow in the laboratory of Nobel Prize winner Julius Axelrod, Ph.D. He returned to Hopkins in 1973 to complete his Psychiatric residency, in which he is board certified, and joined the faculty. In 1980 he was promoted to Professor of Neuroscience and Psychiatry; and in 1982 he assumed the Directorship of the Division of Child and Adolescent Psychiatry, being named the Distinguished Service Professor in 1985. Dr. Coyle is a member of the Institute of Medicine of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences, a fellow of the American Psychiatric Association, a fellow of the American College of Psychiatry and served on the National Advisory Mental Health Council for the National Institute of Mental Health. He is President-Elect of the American College of Neuropsychopharmacology and is a Past President (1991) of the Society for Neuroscience. He has been named the Editor-in-Chief of the Archives of General Psychiatry.

Daniel Geschwind, M.D., Ph.D. 
Dr. Geschwind is a Professor of Neurology, Psychiatry and Genetics, and Director of the Neurogenetics Program and Center for Autism Research at UCLA. He received an A.B. in chemistry, with a minor in psychology at Dartmouth College in 1982; MD and Ph.D degrees at Yale University School of Medicine (1991). He came to UCLA to do his neurology residency (1991-1995), where he remained to develop the program in neurogenetics. He received the 2004 Derek Denny-Brown Neurological Scholar Award from the American Neurological Association and serves on several review and advisory boards including: 1999-2004 Chair, Steering Committee, Autism Genetic Resource Exchange; 2002- Editorial board, Lancet Neurology; 2003-present, 2004-Chair, Education Committee, Society for Neuroscience; 2004- Associate Editor, Neurobiology of Disease; March of Dimes scientific review committee 2004-present. Dr. Geschwind's laboratory performs studies on the genetic basis of human cognitive specializations from the perspective of normal development and diseases, including autism and other neurodevelopmental disorders and focal neurodegenerative syndromes, such as Frontotemporal dementia and Alzheimer's disease. The laboratory uses a wide variety of methods including molecular genetics, DNA microarrays, bio-informatics, cell culture and animal models. Working with other laboratories, his group is performing collaborative comparisons of human brain regions important in creative processes such as language with other species like the songbird, mouse, and non-human primates to help understand the unique, cognitive and creative abilities of the human.

Gary Goldstein, M.D. 
Dr. Goldstein is President and Chief Executive Officer, Kennedy Krieger Institute, one of the nation's leading treatment centers for autism and other developmental disorders. He is Professor at Johns Hopkins University's School of Medicine and Professor of Environmental Health Sciences at Johns Hopkins University's School of Hygiene and Public Health. As one of the leading researchers of neurological functions and defects, Dr. Goldstein has helped gain international recognition for the Kennedy Krieger Institute through his studies of children with a wide range of disabilities, from rare genetic disorders to common learning problems. More than 13,000 children with disabilities visit the Kennedy Krieger Institute every year.

Craig Newschaffer, Ph.D.
Dr. Newschaffer is Professor and Chairman of the Department of Epidemiology and Biostatistics at the Drexel University School of Public Health. Dr. Newschaffer has recently joined the Drexel faculty, coming from the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. At Johns Hopkins, Dr. Newschaffer founded and directed the Center for Autism and Developmental Disabilities Epidemiology, one of five federally funded centers of excellence in autism epidemiology. Major initiatives included the development of methods for monitoring autism spectrum disorders prevalence and participation in the largest population-based epidemiologic study of autism risk factors to date – the National CADDRE Study of Autism and Child Development. Dr. Newschaffer is also engaged in other projects focusing on how particular genes might interact with environment exposures to increase autism risk. His recently began collaboration with Peking University to explore approaches for conducting epidemiologic research on autism in China. Dr. Newschaffer is an Associate Editor of the American Journal of Epidemiology and a member of the editorial board of the journal, Developmental Epidemiology.

Glenn Rall, Ph.D.
Dr. Rall is an Associate Professor at Fox Chase Cancer Center, where he is the Program Leader of the Viral Pathogenesis group. He holds adjunct appointments at the University of Pennsylvania School of Medicine, the Drexel University School of Medicine, and the Microbiology and Immunology Department at Thomas Jefferson University. Dr. Rall received a BS with Honors in Biology in 1985 from Lafayette College and a Ph.D. in Microbiology and Immunology from Vanderbilt University in 1990. Rall joined the Fox Chase faculty in 1996 following a fellowship at the Scripps Research Institute. He is internationally recognized for his studies of viral infection and immunity within the central nervous system, and serves on the editorial boards ofPLoS PathogensJournal of Virology and Viral Immunology.

Robert H. Ring, Ph.D.
Robert H. Ring, Ph.D. served as senior director and head of the Autism Research Unit at Pfizer Worldwide Research and Development. There he led the first research group in the history of the pharmaceutical industry focused specifically on the discovery and development of medicines for neurodevelopmental disorders. Ring also served on its executive leadership team for neuroscience and played an instrumental role in shaping the development of Pfizer’s strategy for autism spectrum disorders. Ring earned a B.A. double major in both Fine Art and Biology from Westmont College in Santa Barbara, CA, and a Ph.D. in Molecular Neurobiology from the City of Hope National Medical Center in Southern California. He holds adjunct faculty appointments in the Departments of Psychiatry at Mount Sinai School of Medicine (New York) and Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia).

Ricki G. Robinson, M.D., M.P.H.
Dr. Robinson is the Co-director of the Descanso Medical Center for Development and Learning, Clinical Professor of Pediatrics at the University of Southern California School of Medicine, Senior Attending Physician at Children's Hospital Los Angeles, and private pediatric physician at HMF/Descanso Pediatrics in La Canada. She has devoted endless hours to education, legislative, and research efforts on behalf of children with Autism Spectrum Disorders. She has organized two Autism task forces in Southern California and stimulated research efforts within these institutions. Dr. Robinson serves on the board of the Interdisciplinary Council on Developmental and Learning Disorders (ICDL) and the editorial board for the Journal of Development and Learning Disorders. She has published numerous articles and chapters in a variety of publications, and she is a nationally recognized speaker on the topic of biomedical approaches to and development of multidisciplinary treatment plans for children who have autism spectrum disorders.

Roberto Tuchman, M.D., FAAN, FAAP
Dr. Tuchman is the director of the Autism Program at Miami Children's Hospital and the consulting medical director of the Center for Autism and Related Disorders at the University of Miami. He was the Founding Director of the Miami Children's Hospital Dan Marino Center for children with autism and related developmental disorders serving as its executive medical director from its start in 1998 thru 2001. Dr. Tuchman is a member of three research groups in South Florida, the Miami Children's Hospital Brain Institute, the Marino Autism Research Institute (MARI) at the University of the Miami, and the Miami Autism Genetic International Consortium (MAGIC) of the University of Miami Miller School of Medicine Human Genome Project. His research interest is in the relationship of epilepsy and autism. Dr. Tuchman is an Associate Professor of Neurology at University of Miami Miller School of Medicine, Miami Children's Hospital. He earned his M.D. from New York University School of Medicine and is certified by the American Board of Pediatrics and the American Board of Psychiatry and Neurology with Special Qualification in Child Neurology. He is a fellow of both the American Academy of Pediatrics and the American Academy of Neurology.